Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s share price traded up 6.2% during mid-day trading on Thursday . The stock traded as high as $47.00 and last traded at $46.2144. Approximately 5,030 shares were traded during trading, an increase of 253% from the average daily volume of 1,424 shares. The stock had previously closed at $43.5016.
Hikma Pharmaceuticals Stock Performance
The business’s 50 day moving average is $41.18 and its 200 day moving average is $39.27.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
